Publication: Behcet's disease in patients with chronic myelogenous leukemia: Possible role of interferon-alpha treatment in the occurrence of Behcet's symptoms
dc.contributor.author | DİRESKENELİ, RAFİ HANER | |
dc.contributor.authors | BudakAlpdogan, T; Demircay, Z; Alpdogan, O; Direskeneli, H; Ergun, T; Bayik, M; Akoglu, T | |
dc.date.accessioned | 2022-03-12T16:56:28Z | |
dc.date.available | 2022-03-12T16:56:28Z | |
dc.date.issued | 1997 | |
dc.description.abstract | Two patients with chronic myelogenous leukemia (CML) who developed characteristic features of Behcet's disease (ED) during alpha-interferon (IFN-alpha) treatment and another patient who had a diagnosis of ED preceding CML are presented. In the first two patients, features of ED appeared 6 months after the initiation of IFN-alpha treatment; they included recurrent oral aphthae, genital ulceration, arthritis, folliculitis, and a positive skin pathergy test. The third patient, however, had a diagnosis of Behcet's disease 4 years before diagnosis of Philadelphia-positive CML. We prospectively examined the skin pathergy reaction in a group of patients with CML, multiple myeloma, and hairy cell leukemia both before and after IFN-alpha treatment and found two additional patients with CML who developed a positive skin pathergy test following IFN-alpha treatment. | |
dc.identifier.doi | 10.1007/s002770050255 | |
dc.identifier.issn | 0939-5555 | |
dc.identifier.pubmed | 9031616 | |
dc.identifier.uri | https://hdl.handle.net/11424/226765 | |
dc.identifier.wos | WOS:A1997WE92200010 | |
dc.language.iso | eng | |
dc.publisher | SPRINGER VERLAG | |
dc.relation.ispartof | ANNALS OF HEMATOLOGY | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Behcet's disease | |
dc.subject | chronic myelogenous leukemia | |
dc.subject | pathergy reaction | |
dc.subject | adverse effect | |
dc.subject | alpha-interferon | |
dc.subject | CHRONIC MYELOID-LEUKEMIA | |
dc.subject | PROGENITOR CELLS | |
dc.subject | THERAPY | |
dc.title | Behcet's disease in patients with chronic myelogenous leukemia: Possible role of interferon-alpha treatment in the occurrence of Behcet's symptoms | |
dc.type | article | |
dspace.entity.type | Publication | |
local.avesis.id | bfb83756-4875-4842-b6f0-d11a6c3b96ea | |
local.import.package | SS17 | |
local.indexed.at | WOS | |
local.indexed.at | SCOPUS | |
local.indexed.at | PUBMED | |
local.journal.numberofpages | 4 | |
oaire.citation.endPage | 48 | |
oaire.citation.issue | 1 | |
oaire.citation.startPage | 45 | |
oaire.citation.title | ANNALS OF HEMATOLOGY | |
oaire.citation.volume | 74 | |
relation.isAuthorOfPublication | 07a34d26-21f3-475d-bd36-152d6c659370 | |
relation.isAuthorOfPublication.latestForDiscovery | 07a34d26-21f3-475d-bd36-152d6c659370 |